BENGALURU: Following an agreement in August, CELLINK, a leader in bioprinter development and the Indian Institute of Science (IISc) on Friday inaugurated the country’s first 3D bioprinting Center of Excellence (CoE), which will focus on providing researchers tools to advance discoveries in tissue engineering, regenerative medicine and drug discovery.
“Housed in the Centre for BioSystems Science and Engineering (BSSE) at IISc, the CoE will provide access to 3D bioprinting systems, enabling researchers to accelerate their work across critical applications with the ultimate goal of improving health outcomes,” IISc said in a release.
Karnataka higher education minister CN Ashwath Narayan was present during the inauguration, IISc said, adding that the CoE, at present houses several CELLINK instruments, including the “BIO X, BIO X6 and the BIONOVA X”, which will officially be accessible to the region’s current and future researchers.
“Housed in the Centre for BioSystems Science and Engineering (BSSE) at IISc, the CoE will provide access to 3D bioprinting systems, enabling researchers to accelerate their work across critical applications with the ultimate goal of improving health outcomes,” IISc said in a release.
Karnataka higher education minister CN Ashwath Narayan was present during the inauguration, IISc said, adding that the CoE, at present houses several CELLINK instruments, including the “BIO X, BIO X6 and the BIONOVA X”, which will officially be accessible to the region’s current and future researchers.
“This centre offers the most cutting-edge and industry-leading 3D Bioprinting technology that we at CELLINK have developed, systems that will enable significant strides in research and in developing the future of health. We are extremely proud to be able to partner with IISc, an institute at the forefront of scientific research as can be seen by the new Medical School being led by Director Prof Govindan Rangarajan,” said Ms Tomoko Bylund, head of sales, CELLINK.
Rangarajan said this initiates efforts in frontier technology which can greatly accelerate development of therapies, drug discovery, personalised medicine and many other applications that can have tremendous impact on human health.
